These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32212957)

  • 1. An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug.
    Vorobjev YN
    J Biomol Struct Dyn; 2021 Apr; 39(7):2352-2363. PubMed ID: 32212957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel].
    Vorobjev YN
    Mol Biol (Mosk); 2020; 54(2):321-332. PubMed ID: 32392203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
    Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
    J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A virus M2 ion channel protein: a structure-function analysis.
    Holsinger LJ; Nichani D; Pinto LH; Lamb RA
    J Virol; 1994 Mar; 68(3):1551-63. PubMed ID: 7508997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategy for high throughput screening of anti-influenza virus M2 ion channel inhibitors.
    Li C; Long Y; Lin Z; Jie Y; Xiao Y; Yang L; Sun J; Ren Y; Chen L; Li Z
    Curr Pharm Des; 2013; 19(28):5146-55. PubMed ID: 23621591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
    Leonov H; Astrahan P; Krugliak M; Arkin IT
    J Am Chem Soc; 2011 Jun; 133(25):9903-11. PubMed ID: 21534619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitations.
    Kumar G; Sakharam KA
    Eur J Med Chem; 2024 Mar; 267():116172. PubMed ID: 38330869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
    Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
    J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
    Wang C; Takeuchi K; Pinto LH; Lamb RA
    J Virol; 1993 Sep; 67(9):5585-94. PubMed ID: 7688826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion selectivity and activation of the M2 ion channel of influenza virus.
    Shimbo K; Brassard DL; Lamb RA; Pinto LH
    Biophys J; 1996 Mar; 70(3):1335-46. PubMed ID: 8785289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid-State NMR.
    Stampolaki Μ; Hoffmann A; Tekwani K; Georgiou K; Tzitzoglaki C; Ma C; Becker S; Schmerer P; Döring K; Stylianakis I; Turcu AL; Wang J; Vázquez S; Andreas LB; Schmidtke M; Kolocouris A
    ChemMedChem; 2023 Aug; 18(16):e202300182. PubMed ID: 37377066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protonation equilibria and pore-opening structure of the dual-histidine influenza B virus M2 transmembrane proton channel from solid-state NMR.
    Williams JK; Shcherbakov AA; Wang J; Hong M
    J Biol Chem; 2017 Oct; 292(43):17876-17884. PubMed ID: 28893910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2 protein-a proton channel of influenza A virus.
    Betakova T
    Curr Pharm Des; 2007; 13(31):3231-5. PubMed ID: 18045172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.